We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-3.36%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$515M
AUM Growth
-$30.1M
Cap. Flow
-$7.12M
Cap. Flow %
-1.38%
Top 10 Hldgs %
16.03%
Holding
304
New
12
Increased
100
Reduced
100
Closed
22

Top Buys

Rank Stock Value
1
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$1.65M
2
ETN icon
Eaton
ETN
+$645K
3
OII icon
Oceaneering
OII
+$550K
4
CTSH icon
Cognizant
CTSH
+$485K
5
BPL
Buckeye Partners, L.P.
BPL
+$414K

Top Sells

Rank Stock Value
1
TCOM icon
Trip.com Group
TCOM
+$1.19M
2
AME icon
Ametek
AME
+$1.17M
3
AMX icon
America Movil
AMX
+$674K
4
JPM icon
JPMorgan Chase
JPM
+$542K
5
C icon
Citigroup
C
+$501K

Sector Composition

Rank Sector Weight
1 Technology 21.45%
2 Industrials 17.09%
3 Financials 8.7%
4 Healthcare 8.6%
5 Energy 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VERU icon
251
Veru
VERU
$36.9M
$257K 0.05%
7,360
-2,352
-24% -$97.1K
OSG
252
Octave Specialty Group
OSG
$276M
$254K 0.05%
11,500
– –
LUV icon
253
Southwest Airlines
LUV
$23.6B
$253K 0.05%
7,500
– –
EPD icon
254
Enterprise Products Partners
EPD
$83.9B
$242K 0.05%
6,000
– –
LNG icon
255
Cheniere Energy
LNG
$55.5B
$240K 0.05%
3,000
– –
EQNR icon
256
Equinor
EQNR
$88.8B
$237K 0.05%
8,726
-2,366
-21% -$68.3K
ALNY icon
257
Alnylam Pharmaceuticals
ALNY
$36.4B
$234K 0.05%
+3,000
New +$194K
ROC
258
DELISTED
ROCKWOOD HLDGS INC
ROC
$229K 0.04%
3,000
– –
HAL icon
259
Halliburton
HAL
$29.3B
$225K 0.04%
3,492
+395
+13% +$27.1K
FGP
260
DELISTED
Ferrellgas Partners, L.P.
FGP
$215K 0.04%
7,984
-1,454
-15% -$39.2K
FLR icon
261
Fluor
FLR
$6.91B
$212K 0.04%
3,176
– –
AFSI
262
DELISTED
AmTrust Financial Services, Inc.
AFSI
$210K 0.04%
+10,564
New +$223K
DRC
263
DELISTED
DRESSER-RAND GROUP INC
DRC
$208K 0.04%
+2,530
New +$170K
CYS
264
DELISTED
CYS Investments Inc.
CYS
$206K 0.04%
+25,000
New +$225K
EW icon
265
Edwards Lifesciences
EW
$48.9B
$204K 0.04%
+12,000
New +$189K
GS icon
266
Goldman Sachs
GS
$311B
$203K 0.04%
+1,107
New +$194K
CCL icon
267
Carnival Corporation Ltd
CCL
$35.7B
$201K 0.04%
+5,000
New +$189K
ZBH icon
268
Zimmer Biomet
ZBH
$17.4B
$201K 0.04%
2,060
– –
TIO
269
DELISTED
Tingo Group, Inc. Common Stock
TIO
$145K 0.03%
42,026
-19,357
-32% -$68.4K
PGH
270
DELISTED
Pengrowth Energy Corporation
PGH
$108K 0.02%
20,771
+5,300
+34% +$33K
AEG icon
271
Aegon
AEG
$13.4B
– –
-29,459
Closed -$175K
AME icon
272
Ametek
AME
$53.9B
– –
-22,350
Closed -$1.17M
BDC icon
273
Belden
BDC
$3.88B
– –
-3,000
Closed -$234K
BKTI icon
274
BK Technologies
BKTI
$296M
– –
-4,000
Closed -$77K
BPOP icon
275
Popular Inc
BPOP
$11.1B
– –
-6,500
Closed -$222K
8 9 10
11
12

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q3 2014 Portfolio in Review

As of Q3 2014, Stanley-Laman Group held 304 positions worth $515M, down 5.5% from $545M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q3 2014 filing shows 12 new, 100 increased, 100 reduced and 22 closed positions. Its largest new stake was Eagle Pharmaceuticals, Inc.: 132,790 shares worth $1.68M. The largest sale was Trip.com Group, an estimated $1.19M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

  • Stanley-Laman Group's largest Q3 2014 buy was Eagle Pharmaceuticals, Inc.: 132,790 shares worth $1.68M.
  • Stanley-Laman Group added most to Eaton in Q3 2014, an estimated $645K increase.
  • Stanley-Laman Group's biggest Q3 2014 reduction was Trip.com Group, cutting an estimated $1.19M.
  • Stanley-Laman Group fully exited Ametek in Q3 2014, selling an estimated $1.17M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $515M portfolio in Q3 2014.
  • Stanley-Laman Group opened 12 new positions and closed 22 in Q3 2014.
  • Stanley-Laman Group's portfolio value fell 5.5% quarter-over-quarter to $515M.

Based on Stanley-Laman Group's 13F filing for Q3 2014, filed 14 Nov 2014.